Skip to content
Clinical Trials – home

Dexrazoxane: A Protective Agent for Cancer Patients

2 / 2
trials open to patients / all trials
12+
Countries

In short

Dexrazoxane is a drug being studied in clinical trials for its potential to protect the heart from damage caused by certain cancer treatments, particularly anthracycline chemotherapy drugs. This article explores how dexrazoxane is being investigated to prevent heart problems in cancer patients and treat accidental extravasation of chemotherapy drugs.

At a glance

Primary Use
Cardioprotection during anthracycline chemotherapy
Secondary Use
Treatment of anthracycline extravasation
Administration
Intravenous infusion, typically before chemotherapy
Patient Groups
Adults and children with various cancers, including breast cancer and soft tissue sarcoma
Dosage Range
Varies by trial, often 10:1 ratio to anthracycline dose
Outcome Measures
Heart function, progression-free survival, reduction in tissue damage
Safety Monitoring
Blood tests, cardiac function tests, adverse event reporting

What is Dexrazoxane?

Dexrazoxane is a medication primarily used to protect the heart from damage caused by certain chemotherapy drugs, particularly anthracyclines like doxorubicin. It's also known by brand names such as Zinecard, Totect, and Cardioxane. Dexrazoxane acts as a cardioprotectant, which means it helps shield the heart from potential harm during cancer treatment.

How Dexrazoxane Works

Dexrazoxane works in several ways to protect the heart: It reduces the formation of harmful reactive oxygen species (ROS), which are unstable molecules that can damage heart cells. It helps prevent apoptosis, which is a process of programmed cell death that can affect heart muscle cells. It targets an enzyme called Topoisomerase 2b in the blood, which is thought to play a role in heart damage caused by certain chemotherapy drugs. By protecting the heart, dexrazoxane allows patients to receive higher doses of chemotherapy or continue treatment for longer periods, potentially improving their cancer outcomes.

Conditions Treated with Dexrazoxane

Dexrazoxane is used in various medical scenarios: Cancer Treatment: It's primarily used alongside chemotherapy for various cancers, including breast cancer and soft tissue sarcomas. Anthracycline Extravasation: Dexrazoxane can be used to treat accidental leakage of anthracycline chemotherapy drugs into surrounding tissues, which can cause severe damage. Congenital Heart Surgery: Research is being conducted to see if dexrazoxane can protect the hearts of infants and young children during heart surgery.

How Dexrazoxane is Administered

Dexrazoxane is typically given as an intravenous (IV) infusion, which means it's delivered directly into a vein. The dosage and schedule can vary depending on the specific treatment plan: For cancer treatment, it's often given before the chemotherapy drug, usually at a ratio of 10 parts dexrazoxane to 1 part doxorubicin. In cases of anthracycline extravasation, it may be given once daily for three consecutive days. For heart surgery in infants, researchers are studying various dosing regimens. The exact dosage and timing will be determined by your healthcare provider based on your specific condition and treatment plan.

Current Clinical Trials

Several clinical trials are currently exploring new uses for dexrazoxane: Testing its effectiveness in preventing heart failure in breast cancer patients receiving doxorubicin. Investigating its use in protecting the hearts of infants and young children during congenital heart surgery. Evaluating its role in treating accidental extravasation (leakage) of anthracycline chemotherapy drugs. Studying its use alongside other cancer treatments for soft tissue sarcomas. These trials aim to expand our understanding of how dexrazoxane can be used to protect patients from various forms of heart damage.

Potential Side Effects

While dexrazoxane is generally well-tolerated, it may cause some side effects. Common side effects can include: Nausea or vomiting Fatigue Decreased white blood cell count (which can increase the risk of infections) Your healthcare provider will monitor you closely for any side effects and adjust your treatment as necessary. It's important to report any unusual symptoms or side effects to your doctor promptly.

Questions people often ask

Conditions where Dexrazoxane is being studied

Each condition opens its own overview and trial list

Trials with Dexrazoxane

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.